Updated:
HBM Genomics
HBM Genomics is a life sciences investment firm founded in 2014 in Palo Alto, California. It invests in early-stage companies and partners with founders on...
Overview
HBM Genomics is a life sciences investment firm founded in 2014 in Palo Alto, California. It invests in early-stage companies and partners with founders on strategy, hiring, funding, and scaling. HBM Genomics has made eight investments, including a Series A investment in Galatea Bio on March 27, 2025.
General information
Firm type
Private Equity
Year founded
2014
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Sector focus
Frequently asked questions
Which sectors does HBM Genomics explicitly avoid?
Publicly available information does not specify excluded sectors, but the firm concentrates exclusively on genomics, AI/ML in life sciences, and digital health, implying it avoids general industrial tech, real estate, or consumer-facing ventures.
Where is HBM Genomics based, and does it have additional offices?
The firm is headquartered in San Francisco, California. No additional office locations have been publicly disclosed.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: